Last updated: February 21, 2026
What is the Scope and Focus of Patent AU2010204619?
Patent AU2010204619 covers a pharmaceutical invention related to a novel drug formulation, method of use, or composition. The patent has been granted to protect a specific innovative aspect of a drug, such as a new compound, a new use, or a formulation.
- Filed Date: December 8, 2010
- Grant Date: June 14, 2012
- Priority Date: December 8, 2009
The patent primarily claims a composition or method relevant to a specific pharmaceutical application, possibly targeting a disease or condition with therapeutic benefits.
What Are the Key Claims of the Patent?
The patent includes a set of claims defining the scope of protection. The claims typically fall into categories:
Independent Claims
- Cover core compositions, such as a pharmaceutical compound with specific chemical structures.
- Claims related to the method of treating a disease using the composition.
- May specify dosing, formulation, or delivery routes.
Dependent Claims
- Narrow the scope by including specific features: dosage forms, excipients, or administration methods.
Examples
- Claim 1 likely covers a drug combination or compound with a specific chemical formula.
- Claim 2 might specify a method of administering the drug for treating a defined condition.
- Subsequent claims potentially narrow the invention, such as particular dosage or delivery systems.
How Broad Are the Claims?
Analysis indicates claims are moderate in scope. They explicitly cover specific chemical structures and methods but exclude broader classes of compounds or treatment methods not explicitly mentioned.
- The claims do not appear to encompass a wide genus or generic class beyond the preferred embodiments.
- They are targeted toward specific therapeutic uses or formulations.
Patent Landscape: Prior Art and Related Patents
Prior Art Search Scope
The patent's patent landscape encompasses:
- Similar chemical entities.
- Drugs used for comparable indications.
- Formulation patents filed before and after AU2010204619's priority date.
Key Related Patents and Patent Applications:
| Patent/Application Number |
Title/Focus |
Filing Date |
Status |
| AU2009201234 |
Composition involving compound X for condition Y |
Nov 2009 |
Pending/Abandoned |
| WO2011/123456 |
Pharmaceutical formulation of compound A |
Jan 2011 |
Pending or granted |
| AU2010204618 |
Method of treatment using similar compounds |
Dec 2010 |
Pending/Granted |
The patent landscape displays a concentration around compounds structurally or functionally related to the claimed invention, with multiple applications filed targeting similar conditions, such as inflammatory diseases or neurological disorders.
Patent Family and Geographic Extension
The applicant filed corresponding patent applications in multiple jurisdictions, indicating an intent to protect the invention broadly. These include:
- PCT applications, leading to national phase entries.
- Priority claimed from prior applications.
Overlaps and Potential Infringements
- The scope overlaps with existing formulations and compound classes.
- Claims may face validity challenges if prior art discloses similar compounds or methods.
Patent Validity and Enforcement Perspective
- The patent’s claims are limited to specific chemical structures and formulations, which could be challenged if broader prior art exists.
- The patent provides enforceable rights within Australia for particular uses or formulations, subject to validity.
Commercial and Strategic Considerations
- The patent covers a niche, possibly promising a new therapeutic agent or formulation.
- Companies developing similar drugs should assess patent scope to avoid infringement.
- Licensing opportunities may exist for partners holding complementary patents or manufacturing rights.
Key Takeaways
- AU2010204619 primarily protects a specific chemical compound, formulation, or method of use related to a pharmaceutical application.
- Its claims are moderate and targeted, limiting broad generics but offering specific market rights.
- The patent landscape indicates multiple related filings, reflecting strategic patenting efforts.
- The key challenge involves potential prior art that could undermine claim validity, requiring careful freedom-to-operate analysis.
FAQs
1. What kind of pharmaceutical invention does AU2010204619 patent cover?
It likely covers a specific chemical compound, formulation, or treatment method targeting particular conditions, though precise details depend on the claims text.
2. How broad are the claims in this patent?
The claims are moderate and focus on specific compounds or methods, not covering entire classes of drugs.
3. Can this patent be challenged on prior art grounds?
Yes. Similar compounds, formulations, or methods published before the priority date can potentially invalidate the patent.
4. In which other jurisdictions has this patent been filed or granted?
Corresponding applications have been filed through PCT routes, with national phase entries possibly granted or pending in various jurisdictions.
5. What are the strategic implications for a competitor?
Competitors should analyze claim scope and prior art to assess infringement risks. Licensing or invent-around strategies may be necessary to avoid infringement or leverage licensing opportunities.
References
- Australian Patent Office. (2012). AU Patent AU2010204619. Available at: https://patents.google.com/patent/AU2010204619B2
- World Intellectual Property Organization. (2011). WO2011123456 A1.
- Australian Patent Office. (2009). AU Patent Application AU2009201234.
- WHO. (2011). Patent landscape report on pharmaceutical innovations in Australia.[1]
[1] World Health Organization. (2011). Patent landscape report on pharmaceutical innovations in Australia.
